Explore All 295 IPO Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | March 21, 2025 |
| Target | Visen Pharma |
| Sector | Life Science |
| Sellers(s) |
Vivo Capital
HBM Partners Ascendis Pharma |
| Deal Type | IPO |
FILTER BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 5.3B USD |
| Size | Mega |
| Type | Sector Focused |
Vivo Capital is a healthcare investment firm focused on opportunities throughout the US and China. Specific areas of interest include biopharmaceuticals, specialty pharmaceuticals, and medical devices. The Firm looks to identify and work with companies at the development and commercial stage products in the US and at the revenue stage in China. Vivo Capital was established in 1996 and is headquartered in Palo Alto, California.
| Deal Context for Seller | # |
|---|---|
| Overall | 17 of 17 |
| Sector: Life Science | 10 of 10 |
| Type: IPO | 13 of 13 |
| Country: China | 1 of 1 |
| Year: 2025 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-06 |
Bonraybio
Taichung City, Taiwan Bonraybio specializes in precision testing and optical technology. Bonraybio was founded in 2015 and is based in Taichung City, Taiwan. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 2.1B USD |
| Size | Large |
| Type | Sector Focused |
HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.
| Deal Context for Seller | # |
|---|---|
| Overall | 38 of 40 |
| Sector: Life Science | 34 of 35 |
| Type: IPO | 30 of 30 |
| Country: China | 4 of 4 |
| Year: 2025 | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-18 |
Sai Life
Hyderabad, India Sai Life is an integrated provider of drug discovery, development, and manufacturing solutions for innovator pharmaceutical and biotechnology companies. The company’s ongoing commitment to quality, thorough approach, and state-of-the-art research and manufacturing facilities enable its highly skilled team of professionals to provide its clients with competitive advantages such as shorter time to market and risk minimization. Sai Life was founded in 1999 and is based in Hyderabad, Telangana. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-10-15 |
Aculys Pharma
Minato-ku, Japan Aculys Pharma is a biopharmaceutical company focused on the development and commercialization of innovations in the fields of neurology and psychiatry. Aculys Pharma was founded in 2021 and is based in Minato-ku, Japan. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 2006 |
| Sector | Life Science |
| Employees | 1,017 |
| Revenue | 364M EUR (2024) |
Ascendis Pharma is a pharmaceutical company developing improved, patentable versions of high-value drugs. The company’s proprietary TransCon technology is used to generate drug candidates that are more effective and have lower risk than existing drugs, and have new patent life. Ascendis Pharma was founded in 2006 and is based in Hellerup, Denmark.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: IPO | 1 of 1 |
| Country: China | 1 of 1 |
| Year: 2025 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-11-08 |
Visen Pharma
Shanghai, China Visen Pharma is a biopharmaceutical company focused on endocrine-related treatments. It is committed to providing more humane and innovative therapies to enable endocrine patients to enjoy better treatment processes and efficacy, achieving their desired lives. Visen Pharma was founded in 2018 and is based in Shanghai, China. |
Buy | - |
